Bone marrow microenvironment in cancer patients: immunological aspects and clinical implications

The bone marrow (BM) of cancer patients is considered an essential secondary lymphoid organ with substantial impact on tumor cell dissemination and tumor-immune responses. Recent advances in the understanding of BM/primary tumor crosstalk, homing processes, premetastatic niche formation, tumor cell...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefanovic, Stefan (Author) , Schütz, Florian (Author) , Sohn, Christof (Author) , Beckhove, Philipp (Author) , Domschke, Christoph (Author)
Format: Article (Journal)
Language:English
Published: 2013
In: Cancer and metastasis reviews
Year: 2013, Volume: 32, Issue: 1, Pages: 163-178
ISSN:1573-7233
DOI:10.1007/s10555-012-9397-1
Online Access:Verlag, Volltext: http://dx.doi.org/10.1007/s10555-012-9397-1
Verlag, Volltext: https://doi.org/10.1007/s10555-012-9397-1
Get full text
Author Notes:Stefan Stefanovic, Florian Schuetz, Christof Sohn, Philipp Beckhove, Christoph Domschke
Description
Summary:The bone marrow (BM) of cancer patients is considered an essential secondary lymphoid organ with substantial impact on tumor cell dissemination and tumor-immune responses. Recent advances in the understanding of BM/primary tumor crosstalk, homing processes, premetastatic niche formation, tumor cell dormancy, and ultimately, identification of the BM micromilieu cytokines, chemokines, and growth factors may provide the basis for the development of targeted therapeutic strategies potentially rendering primary cancers and cancer bone metastases more susceptible to chemotherapy. The present review aims to dissect the individual components of the BM microenvironment in cancer patients, compare it to the healthy BM, and discuss its impact on interactions between the tumor and the immune system.
Item Description:First Online: 19 October 2012
Gesehen am 20.09.2018
Physical Description:Online Resource
ISSN:1573-7233
DOI:10.1007/s10555-012-9397-1